Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01338987
Title Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

acute myeloid leukemia

bone marrow cancer

acute lymphoblastic leukemia

Therapies

Tacrolimus

Busulfan

Methotrexate

Leuprolide

Cyclophosphamide

Fludarabine

Age Groups: child | adult
Covered Countries USA

Additional content available in CKB BOOST